Dependence on MUC1-C in Progression of Neuroendocrine Prostate Cancer

Castration resistant prostate cancer (CRPC) is responsive to androgen receptor (AR) axis targeted agents; however, patients invariably relapse with resistant disease that often progresses to neuroendocrine prostate cancer (NEPC). Treatment-related NEPC (t-NEPC) is highly aggressive with limited ther...

Descripción completa

Detalles Bibliográficos
Autor principal: Kufe, Donald
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9967814/
https://www.ncbi.nlm.nih.gov/pubmed/36835130
http://dx.doi.org/10.3390/ijms24043719

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9967814/
https://www.ncbi.nlm.nih.gov/pubmed/36835130
http://dx.doi.org/10.3390/ijms24043719

Ejemplares similares